Search - tctmd.com

Displaying 41 - 60 of 126

Sort: Relevancy | Date

Presentation THT 2025

Is There a Difference in the Benefits of AF Ablation in HFrEF vs HFpEF?

Presenter: Andrea Russo

February 11, 2025

Presentation THT 2025

Obese HFpEF Patients Exhibit Distinct Augmentation Patterns of VO2 Components During Exercise

Presenter: Takenori Ikoma

February 11, 2025

Presentation THT 2025

How Regulation of Stressed Blood Volume at Rest and Exercise Contributes to HFpEF Symptomatology

Presenter: Sanjiv Shah

February 11, 2025

Presentation THT 2025

Assessing Determinants of Maximal Exercise Tolerance: What Are the Relative Contributions of PCWP, Ventilatory Anaerobic Threshold and Lactate

Presenter: Yogesh Reddy

February 11, 2025

Presentation THT 2025

Setting Pace in HFpEF: The Rationale for Personalized Heart Rates

Presenter: Harriette Van Spall

February 11, 2025

Presentation THT 2025

Insights Into Hemodynamic Mechanisms of HFpEF From Advanced Invasive Hemodynamic Measurements

Presenter: Philipp Lurz

February 11, 2025

Presentation THT 2025

Session Introduction: Novel Frontiers in HFpEF Diagnostics and Management

Presenter: Kavita Sharma

February 11, 2025

Presentation THT 2025

Renal Dysfunction as a Primary Mechanism of Symptoms in (Most) Patients With HFpEF

Presenter: Jeffrey Testani

February 11, 2025

Presentation THT 2025

Comprehensive Mapping of Exercise Hemodynamic Responses and Multi-Organ System Reserve Capacity in HFpEF and Implications for Individualized Management

Presenter: Isabela Landsteiner

February 11, 2025

Presentation THT 2025

Mechanisms by Which Cardiometablic Drugs Help People Feel Better

Presenter: Barry Borlaug

February 11, 2025

Presentation TCT 2024

TCT 648: HFpEF Phenotype Is Associated With Early Symptom-Onset in Aortic Stenosis and Residual Symptomatic Burden After Transcatheter Aortic Valve Replacement

Presenter: Constantijn Venema

October 30, 2024

Presentation TCT 2024

HFpEF: Devices on the Rise or Fall?

Presenter: Sanjiv Shah

October 28, 2024

Presentation NY Valves 2024

Case Presentation: Aortic Stenosis and Dyspnea – What Do We Call It? Is It HFpEF OR Is It the Valve?

Presenter: Kyle R. Lehenbauer

June 05, 2024

Presentation ACC 2024

Main Results From The Step-hfpef Dm Trial

Presenter: Mikhail Kosiborod

April 06, 2024

Presentation THT 2024

PH-HFpEF: Levosimendan

Presenter: Sanjiv J. Shah

March 06, 2024

Presentation THT 2024

Imaging in HFpEF Trials: Going Beyond Echocardiography

Presenter: Robert O. Bonow

March 05, 2024

Presentation THT 2024

Heart Failure Solutions: The PeriCut Device as a Treatment for HFpEF

Presenter: Mark Strong

March 05, 2024

Presentation THT Abstracts 2024

Association of a Novel, Non-invasive AI Model to Automate Echocardiographic Detection of Heart Failure with Preserved Ejection Fraction (HFpEF) with Invasive Hemodynamics

Presenter: Nadira Hamid

March 04, 2024

Presentation THT 2024

CCM Applied to Patients With HFpEF

Presenter: Javed Butler

March 04, 2024

Presentation THT 2024

Physiological Effects of Renal Denervation in Patients With HFpEF

Presenter: Karl-Philipp Rommel

March 04, 2024

Advertisement

Is There a Difference in the Benefits of AF Ablation in HFrEF vs HFpEF?

Obese HFpEF Patients Exhibit Distinct Augmentation Patterns of VO2 Components During Exercise

How Regulation of Stressed Blood Volume at Rest and Exercise Contributes to HFpEF Symptomatology

Assessing Determinants of Maximal Exercise Tolerance: What Are the Relative Contributions of PCWP, Ventilatory Anaerobic Threshold and Lactate

Setting Pace in HFpEF: The Rationale for Personalized Heart Rates

Insights Into Hemodynamic Mechanisms of HFpEF From Advanced Invasive Hemodynamic Measurements

Session Introduction: Novel Frontiers in HFpEF Diagnostics and Management

Renal Dysfunction as a Primary Mechanism of Symptoms in (Most) Patients With HFpEF

Comprehensive Mapping of Exercise Hemodynamic Responses and Multi-Organ System Reserve Capacity in HFpEF and Implications for Individualized Management

Mechanisms by Which Cardiometablic Drugs Help People Feel Better

TCT 648: HFpEF Phenotype Is Associated With Early Symptom-Onset in Aortic Stenosis and Residual Symptomatic Burden After Transcatheter Aortic Valve Replacement

HFpEF: Devices on the Rise or Fall?

Case Presentation: Aortic Stenosis and Dyspnea – What Do We Call It? Is It HFpEF OR Is It the Valve?

Main Results From The Step-hfpef Dm Trial

PH-HFpEF: Levosimendan

Imaging in HFpEF Trials: Going Beyond Echocardiography

Heart Failure Solutions: The PeriCut Device as a Treatment for HFpEF

Association of a Novel, Non-invasive AI Model to Automate Echocardiographic Detection of Heart Failure with Preserved Ejection Fraction (HFpEF) with Invasive Hemodynamics

CCM Applied to Patients With HFpEF

Physiological Effects of Renal Denervation in Patients With HFpEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content